ConductScience.org, home

Trial · NCT03451734

Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic Patients

NCT03451734, Completed, Central South University

3 sourcestrials-2026-11-12-0.4.0

Download JSON
Cite this record

ConductScience Library. Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic Patients. Trials, record NCT03451734. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03451734

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic Patients
NCT number
NCT03451734
Status
Completed
Enrollment
2,000 participants, actual
Lead sponsor
Central South University
Conditions
Schizophrenia, Metabolic Syndrome
Interventions
antipsychotic medications, adjunctive group, metformin and lifestyle intervention
First posted
2018-03-02
Last updated
2021-08-12

Source ClinicalTrials.gov

Registered outcomes4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryPositive And Negative Syndrome Scale (PANSS)8 weeksThe change of Positive And Negative Syndrome Scale (PANSS) total, positive and negative symptoms before and after treatment at different follow up point.
PrimaryClinical Global Impressions(CGI)8 weeksThe change of Clinical Global Impressions(CGI):severity of illness(SI), global improvement(GI) and efficacy index(EI) before and after treatment at different follow up point.
PrimaryGlobal Assessment Function(GAF)8 weeksThe change of Global Assessment Function(GAF) before and after treatment at different follow up point.
PrimaryMATRICS Consensus Cognitive Battery (MCCB) composite score8 weeksThe investigators will use the MATRICS Consensus Cognitive Battery (MCCB) Composite score as primary cognitive outcome measure before and after treatment at different follow up point.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers8

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
32528286DERIVEDPubMed
33692676DERIVEDPubMed
33716817DERIVEDPubMed
37468932DERIVEDPubMed
37728803DERIVEDPubMed
39049073DERIVEDPubMed
40055632DERIVEDPubMed
42972312DERIVEDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT03451734

GET https://conductscience.org/api/trials/v1/NCT03451734/registered